Islet amyloid in recent-onset type 1 diabetes—the DiViD study

Islet amyloid in recent-onset type 1 diabetes—the DiViD study

Bibliographic Details
Main Authors:	Gunilla T. Westermark, Lars Krogvold, Knut Dahl-Jørgensen, Johnny Ludvigsson
Format:	Article
Language:	English
Published:	Upsala Medical Society 2017-07-01
Series:	Upsala Journal of Medical Sciences
Online Access:	http://dx.doi.org/10.1080/03009734.2017.1359219

Similar Items

High plasma levels of islet amyloid polypeptide in young with new-onset of type 1 diabetes mellitus.
by: Johan F Paulsson, et al.
Published: (2014-01-01)

Characterisation of the endocrine pancreas in type 1 diabetes: islet size is maintained but islet number is markedly reduced
by: Peter Seiron, et al.
Published: (2019-10-01)

Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets
by: Sara Ullsten, et al.
Published: (2017-09-01)

The density of parasympathetic axons is reduced in the exocrine pancreas of individuals recently diagnosed with type 1 diabetes.
by: Marcus Lundberg, et al.
Published: (2017-01-01)

Drosophila melanogaster as a model system for studies of islet amyloid polypeptide aggregation.
by: Sebastian Wolfgang Schultz, et al.
Published: (2011-01-01)

3D analysis of human islet amyloid polypeptide crystalline structures in Drosophila melanogaster.
by: Ling Xie, et al.
Published: (2019-01-01)

Recent Insight in Islet Amyloid Polypeptide Morphology, Structure, Membrane Interaction, and Toxicity in Type 2 Diabetes
by: Lucie Khemtemourian, et al.
Published: (2016-01-01)

Pro-islet amyloid polypeptide and type 2 diabetes
by: Hull, Rebecca L.
Published: (1999)

Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients
by: Rosaura Casas, et al.
Published: (2020-10-01)

The role of calcium, lipid membranes and islet amyloid polypeptide in the onset of type 2 diabetes: innocent bystanders or partners in a crime?
by: Carmelo eLa Rosa, et al.
Published: (2014-12-01)

Impaired pro-islet amyloid polypeptide processing promotes beta-cell dysfunction in diabetes and islet transplants
by: Courtade, Jaques
Published: (2016)

Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model.
by: Per Westermark, et al.
Published: (2009-06-01)

The role of islet amyloid and CHOP in islet graft dysfunction and failure
by: Potter, Kathryn Jane
Published: (2011)

The role of islet amyloid and CHOP in islet graft dysfunction and failure
by: Potter, Kathryn Jane
Published: (2011)

The role of islet amyloid and CHOP in islet graft dysfunction and failure
by: Potter, Kathryn Jane
Published: (2011)

Washingtonia filifera seed extracts inhibit the islet amyloid polypeptide fibrils formations and α-amylase and α-glucosidase activity
by: Sonia Floris, et al.
Published: (2021-01-01)

Formation of amyloid and lipid metabolism in islet pathology of type 2 diabetes
by: Moffitt, Jennifer Helen
Published: (2005)

Islet amyloid polypeptide (IAPP) in Type 2 diabetes and Alzheimer disease
by: Oskarsson, Marie
Published: (2015)

Association of Islet Amyloid Polypeptide and Inflammatory Markers in Type 2 Diabetes Mellitus
by: Zunjarrao Ganpat Badade, et al.
Published: (2021-06-01)

Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes.
by: Linda Åkerman, et al.
Published: (2018-01-01)

Interactions driving the collapse of islet amyloid polypeptide: implications for amyloid aggregation
Published: (2013)

Islet amyloid polypeptide aggregation is a local trigger for pancreatic islet inflammation
by: Westwell-Roper, Clara Yolande
Published: (2014)

Islet amyloid polypeptide aggregation is a local trigger for pancreatic islet inflammation
by: Westwell-Roper, Clara Yolande
Published: (2014)

Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology
by: Rehana Akter, et al.
Published: (2016-01-01)

Fibrillar dimer formation of islet amyloid polypeptides
by: Chi-cheng Chiu, et al.
Published: (2015-09-01)

Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus
by: Lucie Caillon, et al.
Published: (2016-01-01)

Exploring the effect of glycation on the aggregation of islet amyloid polypeptide
by: Hsu, Yi-Hsuan, et al.
Published: (2018)

The Effect of Cholesterol on Membrane-Bound Islet Amyloid Polypeptide
by: Mikkel Christensen, et al.
Published: (2021-04-01)

Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo
by: Xiao-Dan Mo, et al.
Published: (2018-03-01)

Insights into Mechanisms of Amyloid Toxicity: Molecular Dynamics Simulations of the Amyloid andbeta-peptide (Aandbeta) and Islet Amyloid Polypeptide (IAPP)
by: Brown, Anne M.
Published: (2016)

Depletion of spleen macrophages delays AA amyloid development: a study performed in the rapid mouse model of AA amyloidosis.
by: Katarzyna Lundmark, et al.
Published: (2013-01-01)

Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide.
by: Nasrollah Rezaei-Ghaleh, et al.
Published: (2011-01-01)

Genetic associations of type 2 diabetes with islet amyloid polypeptide processing and degrading pathways in asian populations.
by: Vincent Kwok Lim Lam, et al.
Published: (2013-01-01)

Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus
by: Jeong HR, et al.
Published: (2015-11-01)

Electrochemical Assay of Human Islet Amyloid Polypeptide and Its Aggregation
by: Genxi Li, et al.
Published: (2008-09-01)

Biophysical properties, fibril formation and processing of islet amyloid polypeptide
by: Higham, Claire Emily
Published: (1999)

Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis
by: Phuong Trang Nguyen, et al.
Published: (2015-01-01)

Domains in islet amyloid polypeptide important in fibril formation and toxicity
by: Park, Kirily
Published: (2009)

Domains in islet amyloid polypeptide important in fibril formation and toxicity
by: Park, Kirily
Published: (2009)

Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route
by: Johnny Ludvigsson
Published: (2020-02-01)

Cannot write session to /tmp/vufind_sessions/sess_1o9n1ijsbi556rvf9hm7sb267g